Additionally, the 36-month beta value for EOLS is 1.00. There are mixed opinions on the stock, with 4 analysts rating it as a “buy,” 3 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for EOLS is 56.92M and currently, short sellers hold a 16.98% ratio of that float. The average trading volume of EOLS on June 12, 2025 was 996.69K shares.
EOLS) stock’s latest price update
Evolus Inc (NASDAQ: EOLS)’s stock price has increased by 3.75 compared to its previous closing price of 9.87. However, the company has seen a 4.49% increase in its stock price over the last five trading sessions. businesswire.com reported 2025-06-10 that NEWPORT BEACH, Calif.–(BUSINESS WIRE)–Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, is proud to announce it has been recognized with two Shape 2025 Skin Awards: Evolysse™ Recognized as the Best Filler for 2025 with its recently launched injectable hyaluronic acid gel line Best Membership Treatment Model for Club Evolus™, its proprietary consumer rewards program The annual Shape Skin Awards highlight innovation and.
EOLS’s Market Performance
Evolus Inc (EOLS) has experienced a 4.49% rise in stock performance for the past week, with a 2.61% rise in the past month, and a -23.70% drop in the past quarter. The volatility ratio for the week is 3.52%, and the volatility levels for the past 30 days are at 3.06% for EOLS. The simple moving average for the past 20 days is 4.87% for EOLS’s stock, with a -21.81% simple moving average for the past 200 days.
Analysts’ Opinion of EOLS
Many brokerage firms have already submitted their reports for EOLS stocks, with BTIG Research repeating the rating for EOLS by listing it as a “Buy.” The predicted price for EOLS in the upcoming period, according to BTIG Research is $21 based on the research report published on April 17, 2025 of the current year 2025.
Barclays, on the other hand, stated in their research note that they expect to see EOLS reach a price target of $16, previously predicting the price at $10. The rating they have provided for EOLS stocks is “Overweight” according to the report published on January 29th, 2024.
Needham gave a rating of “Buy” to EOLS, setting the target price at $18 in the report published on June 23rd of the previous year.
EOLS Trading at -1.67% from the 50-Day Moving Average
After a stumble in the market that brought EOLS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -42.54% of loss for the given period.
#####
#####
Insider Trading
Reports are indicating that there were more than several insider trading activities at EOLS starting from White Albert G III, who purchase 20,000 shares at the price of $9.45 back on Jun 09 ’25. After this action, White Albert G III now owns 50,378 shares of Evolus Inc, valued at $189,000 using the latest closing price.
Avelar Rui, the See Remarks of Evolus Inc, sale 3,385 shares at $9.87 during a trade that took place back on May 12 ’25, which means that Avelar Rui is holding 359,082 shares at $33,397 based on the most recent closing price.
Stock Fundamentals for EOLS
Current profitability levels for the company are sitting at:
- -0.14 for the present operating margin
- 0.68 for the gross margin
The net margin for Evolus Inc stands at -0.2. The total capital return value is set at -0.25. Equity return is now at value -949.46, with -25.57 for asset returns.
Based on Evolus Inc (EOLS), the company’s capital structure generated 4.69 points at debt to capital in total, while cash flow to debt ratio is standing at -2.74. The debt to equity ratio resting at -1.27. The interest coverage ratio of the stock is -4.06.
Currently, EBITDA for the company is -25.0 million with net debt to EBITDA at 1.11. When we switch over and look at the enterprise to sales, we see a ratio of 2.18. The receivables turnover for the company is 5.8for trailing twelve months and the total asset turnover is 1.29. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.34.
Conclusion
In conclusion, Evolus Inc (EOLS) has seen mixed performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
